Patients with chest pain suspected for non ST-segment elevation acute coronary syndrome (NSTE-ACS) are routinely transferred to the emergency department (ED). A point-of-care (POC) troponin measurement might enable ambulance paramedics to identify low-risk patients in whom ED evaluation is not necessary. The ARTICA trial aims to assess the healthcare cost reduction and safety of a pre-hospital rule-out strategy using a single POC troponin measurement.
Patients with chest pain suspected of a NSTE-ACS are screened by ambulance paramedics. The HEAR score (HEART score without the Troponin component) is assessed and patients with a HEAR score of ≤3 are included. The patients are randomised to 1) pre-hospital rule-out with POC troponin measurement (intervention group) and 2) direct transfer to the ED (standard care group). Primary outcome is healthcare costs after 30 days.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Enrollment
866
Point-of-care troponin measurement for pre-hospital rule-out of acute coronary syndrome
RadboudUMC
Nijmegen, Netherlands
Costs from a healthcare perspective (all costs related to healthcare consumption in-hospital, all outpatient visits including diagnostic tests and general practitioner consultations)
Healthcare costs consist of all costs related to healthcare consumption
Time frame: 30 days
Safety: all cause death, acute coronary syndrome, unplanned revascularisation
Major adverse cardiac events (all cause death, ACS, unplanned revascularisation)
Time frame: 30 days
Costs from a societal perspective (all health effects and changes in resource use caused by an intervention)
Costs from a societal perspective are defined as the sum of the healthcare costs and the costs from productivity losses.
Time frame: 30 days
Safety (all cause death, acute coronary syndrome, unplanned revascularisation)
Major adverse cardiac events (all cause death, ACS, unplanned revascularisation)
Time frame: 6 months
Safety (all cause death, acute coronary syndrome, unplanned revascularisation)
Major adverse cardiac events (all cause death, ACS, unplanned revascularisation)
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.